Long term results of relapsed MCL patients treated with Acalabrutinib.
Home / Resource Library / Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Long term results of relapsed MCL patients treated with Acalabrutinib.